FleetBioprocessing  News

October 2019
 
Fleet Attending Two Key Industry Events in November
 
Fleet Bioprocessing Ltd. will be attending two major industry events next month:
  • Medica (Düsseldorf, 18th – 20th November 2019) – Europe’s largest medical device and in vitro diagnostics exhibition
  • The 12th annual European Bioanalysis Forum (EBF) (Barcelona, 20th – 22nd November 2019) – Europe’s main meeting addressing the use of immunoassays and other bioanalytical techniques to support pharmaceutical development
 
Please contact us using the button below if you would like to talk to us at either of these events.
 




  
September 2019

UK Bioscience Forum 2019

Fleet Bioprocessing Ltd. will be attending the BIA UK Bioscience Forum 2019. This will be held in County Hall, London on 17th October, and is one of the main annual events for the UK biotech community. It is organised by the BIA (Bioindustry Association) which represents over 300 member companies in the biotech sector, including Fleet Bioprocessing Ltd.
  


August 2019

Fleet receive Innovate UK funding for new immunoassay conjugate characterisation project

Fleet Bioprocessing Ltd. announce Innovate UK funding for new larger project on immunoassay conjugate characterisation, in collaboration with the National Physical Laboratory and LGC Ltd. Following on from a successful 3-month initial project completed in March 2019, further funding has been confirmed under the Innovate UK Analysis for Innovators scheme for a more comprehensive 12-month follow-up project. Led by Fleet Bioprocessing Ltd. and entitled Rapid and Inexpensive Characterisation of Immunoassay Conjugates (RIChIC), it will run from September 2019 to August 2020, and will examine in more depth some of the techniques which have already shown promise in predicting conjugate behaviour in immunoassays. The bioanalytical expertise of NPL and LGC will again be harnessed to identify suitably quick and economical techniques to meet this aim.
  

June 2019

Fleet collaboration project data presented at the International Conference on HDX-MS

Fleet Bioprocessing Ltd. recently collaborated with LGC Ltd. and the National Physical Laboratory on a project, funded by Innovate UK under the Analysis for Innovators scheme, and focussing on the characterisation of conjugates for immunoassay use. One of the outputs of this project was a poster on the use of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for this purpose, which was presented at the International Conference on HDX-MS, held on 21 – 24 May 2019 in Banff, Canada. 

Download Poster Here





  

May 2019
 
Fleet to Attend the European Gyrolab Seminar, Milan. June 3-4, 2019.

Fleet Bioprocessing Ltd. has announced that it will be attending the European Gyrolab Seminar, Grand Viscount Palace, Milan on June 3 – 4, 2019.

Fleet Bioprocessing Ltd. will be presenting on the topic of Conjugate quality and its impact on Assay Performance. The seminar is designed to allow existing Gyrolab users and those who wish to find out more about Gyros Protein Technologies and immunoassay advances to network.

Fleet Bioprocessing Ltd. offer unrivalled expertise in the development, validation and manufacture of bioconjugates. They also possess industry-leading expertise in all aspects of immunoassay design, development and validation and are a Certified Assay Transfer and Development Partner for the Gyrolab high-throughput immunoassay platform.

If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing Ltd. using the contact form at the top of this page.
  


April 2019

Fleet are pleased to report the successful completion of their Innovate UK-funded collaboration with the National Physical Laboratory (NPL) and LGC Ltd.

Fleet Bioprocessing Ltd. are pleased to report the successful completion of their Innovate UK-funded collaboration with the National Physical Laboratory (NPL) and LGC Ltd., a three month exploratory project entitled “Faster and Cheaper Techniques for the Characterisation of Immunoassay Conjugates”. This project was funded under the Analysis for Innovators (A4I) programme, and has identified a number of promising analytical techniques for further evaluation.

All three parties have agreed to continue the collaboration, with the aim of gaining approval for a follow-on project in September under the next round of A4I funding. In the meantime NPL and LGC Ltd. are both planning to present results from the project at international meetings.
  


March 2019

Fleet to Attend the RSC 6th Analytical Biosciences Early Career Research Meeting (ECRM19).

Fleet Bioprocessing Ltd. has announced that it will be attending the RSC 6th Analytical Biosciences Early Career Research Meeting on 28th-29th March 2019 at The University of Cambridge, UK. The ECRM was founded in 2014 and aims to engage early career researchers in debate and discussions about all areas of analytical biosciences, and provides the opportunity to network with other researchers in the field.
 
Fleet Bioprocessing Ltd. offer unrivalled expertise in the development, validation and manufacture of bioconjugates. They also possess industry-leading expertise in all aspects of immunoassay design, development and validation and are a Certified Assay Transfer and Development Partner for the Gyrolab high-throughput immunoassay platform.

If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) or Gyrolab assay development, please contact Fleet Bioprocessing Ltd. using the contact form at the top of this page.
  
  
  
January 2019

Research Grant Application – Outcome Successful

Fleet Bioprocessing Ltd. along with research partners LGC Limited and the National Physical Laboratory (NPL) have successfully acquired funding from Innovate UK, the UK’s Innovation Agency, to investigate “Faster and Cheaper Techniques for Characterisation of Immunoassay Conjugates”.

Using expertise from LGC on hydrogen/deuterium exchange mass spectrometry (HDX-MS) and ion mobility spectrometry mass spectrometry (IMS-MS) and from NPL on circular dichroism spectroscopy (CD), Fourier transform infrared spectroscopy (FT-IR) and isothermal titration calorimetry (ITC),  Fleet Bioprocessing Ltd. are assessing state-of-the-art technologies for characterisation of labelled antibody conjugates for immunoassay use, with the aim of better prediction of how successfully the conjugate would perform in an immunoassay.

This 3-month feasibility project will run from January to March 2019, and is intended to identify techniques with potential for further development.


November 2018

Fleet to Attend the EBF 11th Open Symposium in Barcelona.

Fleet Bioprocessing Ltd. has announced that it will be attending the European Bioanalytical Forum 11th Open Symposium on 21st – 23rd November 2018.

The EBF was founded in 2006 with the goal of bringing companies together to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and regulatory issues.
Fleet Bioprocessing Ltd. offer unrivalled expertise in the development, validation and manufacture of bioconjugates. They also possess industry-leading expertise in all aspects of immunoassay design, development and validation and are a Certified Assay Transfer and Development Partner for the Gyrolab high-throughput immunoassay platform.

If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing Ltd. using the contact form at the top of this page.


October 2018

Fleet will be attending the Gyrolab seminar - Automating PK/PD, immunogenicity and affinity measurement at Babraham Research Campus in Cambridge on the 31st October 2018.

If you would like to discuss any aspect of Gyrolab Assay development, ELISA development or Bioconjugation, please contact us on  +44 (0)1252614477 or info@fleetbioprocessing.co.uk to let us know you are attending.


  

Contact Us
Download